ZVRA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ZVRA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Zevra Therapeutics's Machinery, Furniture, Equipment for the quarter that ended in Sep. 2024 was $0.00 Mil.
Zevra Therapeutics's annual Machinery, Furniture, Equipment increased from Dec. 2021 ($0.41 Mil) to Dec. 2022 ($0.57 Mil) and increased from Dec. 2022 ($0.57 Mil) to Dec. 2023 ($0.80 Mil).
The historical data trend for Zevra Therapeutics's Machinery, Furniture, Equipment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zevra Therapeutics Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Machinery, Furniture, Equipment | Get a 7-Day Free Trial | 0.42 | 0.37 | 0.41 | 0.57 | 0.80 |
Zevra Therapeutics Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Machinery, Furniture, Equipment | Get a 7-Day Free Trial | - | 0.80 | - | - | - |
Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.
Watton Corey Michael | director | 22045 KAREN STREET, ELKHORN NE 68022 |
R. Laduane Clifton | officer: VP Fin & Corp Controller | C/O KEMPHARM, INC., 1170 CELEBRATION BLVD., #103, CELEBRATION FL 34747 |
Thomas Anderson | director | 215 FIRST STREET, CAMBRIDGE MA 02142 |
John B Bode | director | C/O TRIBUNE PUBLISHING COMPANY, 202 W. FIRST STREET, LOS ANGELES CA 90012 |
Neil F. Mcfarlane | director, officer: President and CEO | C/O RETROPHIN, INC., 12255 EL CAMINO REAL, SUITE 250, SAN DIEGO CA 92130 |
Joshua Schafer | officer: CCO & EVP, Bus. Development | SHUTTLE PHARMACEUTICALS HOLDINGS, INC., ONE RESEARCH COURT, SUITE 450, ROCKVILLE MD 20850 |
Douglas W Calder | director | 324 S. HYDE PARK AVENUE, SUITE 350, TAMPA FL 33606 |
Wendy L Dixon | director | |
Tamara A Seymour | director | C/O SIGNAL GENETICS, INC., 5740 FLEET STREET, CARLSBAD CA 92008 |
Timothy J. Sangiovanni | officer: VP, Corporate Controller | C/O KEMPHARM, INC., 2500 CROSSPARK RD, STE E-126, CORALVILLE IA 52241 |
Matthew R Plooster | director | 2656 CROSSPARK ROAD, SUITE 100, CORALVILLE IA 52241 |
David S Tierney | director | C/O ABLE LABORATORIES, INC., 6 HOLLYWOOD COURT, CN 1013, SOUTH PLAINFIELD NJ 07080 |
Richard W Pascoe | director | C/O SEELOS THERAPEUTICS, INC., 300 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022 |
Christopher Posner | director | C/O CARA THERAPEUTICS, INC., 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL, STAMFORD CT 06902 |
Travis C Mickle | director, 10 percent owner, officer: President & CEO | 2656 CROSSPARK ROAD, SUITE 100, CORALVILLE IA 52241 |
From GuruFocus
By Marketwired • 08-09-2024
By Marketwired • 11-12-2024
By Marketwired • 07-30-2024
By GuruFocus News • 10-09-2024
By GuruFocus News • 11-13-2024
By GlobeNewswire • 11-11-2024
By Marketwired • 07-09-2024
By Marketwired • 08-08-2024
By GuruFocus News • 11-13-2024
By GuruFocus News • 10-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.